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Students’ Corner
Short Communication
The challenge of head & neck squamous cell carcinoma control in Pakistan
Syed Mohammad Asad Zaidi,1 Nauman Fazal Manzoor,2 Shabbir Akhtar3
Medical Student,1 Department of Biological and Biomedical Sciences,2 Section of Otolaryngology-Head & Neck Surgery,3 Aga Khan University, Karachi.

Despite rapid improvement in technologies, surgical
innovations and multi-disciplinary treatment strategies, the
outcome for HNSCC (Head & Neck Squamous Cell
Carcinoma) patients has not significantly improved in the past
four decades.1 This is particularly disconcerting for SouthAsian countries such as Pakistan, where HNSCC appears to be
one of the most common cancers overall in the population.
Head and neck cancers account for approximately one-fifth of
all cancers in males and about one-tenth in females.2 This data,
in the absence of any comprehensive national cancer resource,
is largely based on experience from institution-based cancer
registries.
As the grave consequences of this rapidly evolving
epidemic are becoming clear, it is important to investigate
mechanisms that can be used to control this disease. This will
require a deeper analysis of the risk factors, of the population
at risk and of the treatment resources that are available.
Unfortunately, as is the case with most of the developing
world, in the face of major infectious diseases such as Malaria
and HIV, malignancies have traditionally occupied a low
priority on healthcare agenda.3 As a result, in a country such
as Pakistan, a cancer diagnosis remains one that invariably
carries significant morbidity or certain mortality. In addition,
this is usually accompanied with severe stigmatization by
society. In the case of HNSCC, a diagnosis often occurs at an
exceedingly young age and at a greatly advanced stage.
Cancer could be potentially debilitating for some of the
world's poorest, as global cancer mortality is expected to
outnumber HIV, TB, and Malaria combined, with 70% of
these deaths occurring in the developing world.4
The single most important prognostic factor, that is
central to the biology of HNSCC, is cervical lymph node
metastasis and its presence can drastically alter the outcome of
the disease, regardless of type and location of the primary
tumour. This loco-regional spread also dictates subsequent
therapy and greatly escalates the costs that will be incurred by
the patient for any intervention. Unfortunately, as our
experience suggests, cases in Pakistan, particularly oral cavity
cancers, are seldom caught before reaching this stage. This
contributes to a major portion of the disease burden and
addressing it could have a great impact in ameliorating some
the disease's effects.
The most effective way with which this can be
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achieved is through targeted screening of high-risk population
groups. However, it is essential that this is accomplished in
low-resource settings that can have practical applicability in
the developing world. This has already been demonstrated
through a cluster-randomized control trial in India. It utilized
visual inspection to achieve significantly reduced mortality in
the intervention group through early detection of malignant
and pre-malignant lesions in high risk population groups.5
Subsequent analyses also revealed significant economic
benefits in terms of incremental cost per life-year saved.6
Other possible adjunctive methods include utilizing toluidine
blue, fluorescence imaging and brush biopsies that may
improve diagnostic sensitivity and specificity. Such screening
programmes can be utilized in a cost-effective manner and at
a large scale by governments through healthcare workers with
minimal training and medical expertise. However, further
research is needed that adequately addresses the impact on
quality of life, possible harms of screening from false positive
or false negative findings, psychological implications and
strains on existing healthcare infrastructure before policy
recommendations can be advocated.7
The second factor that needs to be addressed is of
diagnostic delay that is peculiar to HNSCC in developing
countries. A vast majority of patients present with advancedstage disease and both patient and provider related delay
contributes towards the late diagnosis.8 The silent nature of oral
lesions, misinterpretation of symptoms and lack of awareness
about risk factors and symptoms related to HNSCC contribute
to the high prevalence of patient related delay. Provider related
delay stems from the lack of trained oncologists and associated
treatment facilities. In addition, many patients especially from
rural setups seek help from spiritual healers first in order to get
a quick remedy. Others even after presentation are fearful of
biopsies and are hesitant to accept the diagnosis. These factors
need to be taken into consideration before any large-scale
control programme can be initiated.
Thirdly, cancer intelligence units, in the form of
national cancer registries could have a pivotal role in the longterm control of HNSCC. These units can allow systematic
collection of locally relevant data on cancer incidence,
evaluate changes in these patterns over time and assess the
effect of any interventions associated with a cancer control
programme.9 In the absence of such resources, it is not
703

possible to develop a framework for evidence-based research
that can influence future policy. They may also be able to
provide substantial, unequivocal evidence that will underscore
the importance of HNSCC and of other malignancies in
general as a significant health burden. This will be needed to
create sufficient political priority so that efficient referral
systems, increased awareness amongst healthcare workers,
improved diagnostic and treatment modalities and higher
donor funding can be generated.

next great health challenge. There is an urgent need to improve
awareness about the disease and to introduce populationbased cancer registration and early detection programmes. In
addition, health-services infrastructure and human resources
need to be mobilized to help combat this disease.

1.

Carvalho AL, Singh B, Spiro RH, Kowalski LP, Shah JP. Cancer of the oral
cavity: a comparison between institutions in a developing and a developed
nation. Head Neck 2004; 26: 31-8.

Finally, the importance of primary prevention needs to
be emphasized. Limiting the use of various forms of
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greatly alter the future burden of the disease.
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At present, a wide variation exists globally in cancer
survival between different regions of the world and this
discrepancy is accentuated when rural setups in South-Asia
are brought into consideration. Fortunately, effective and lowcost solutions are on the horizon and the time is now ripe to
investigate and implement them further. HNSCC is Pakistan's
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